CTLA4 and neoplasm: Taken together, the growth delay of both primary tumors (T1) and secondary tumors (T2) was achieved in mice whose primary tumor was treated with LRT, while the addition of CTLA-4 antibody enhanced the radiation-induced antitumor effect.